ProtaGene

ProtaGene is a leading global CRO partner specializing in biotechnology research for the biopharmaceutical, gene, and cell therapy industries. From initial research to product commercialization, ProtaGene delivers the most advanced, integrated, and complete protein and gene analytic capabilities and packages for biologic therapeutics, as well as gene and cell therapy platforms.

With a strong history in analytical leadership, stemming from the merger of Protagen Protein Services in Europe and BioAnalytix in the US, ProtaGene has established itself as a key player in the industry. The addition of GeneWerk’s capabilities in vector safety, integration site analysis, and bioinformatics further solidifies ProtaGene's position. The primary address for ProtaGene is Inselwiesenstraße 10, Heilbronn, Baden-Württemberg 74076, DE. Additionally, ProtaGene has locations at 4 Burlington Woods Dr, Burlington, Massachusetts 01803, US; Im Neuenheimer Feld 582, Heidelberg, Baden-Württemberg 69120, DE; and Otto-Hahn Straße 15, Dortmund, North Rhine-Westphalia 44227, DE.

ProtaGene operates across four sites in Europe and North America, collaborating with leading biopharmaceutical and gene therapy companies worldwide. ProtaGene is dedicated to advancing therapeutic platforms and delivering cutting-edge analytical services. We invite the management team at ProtaGene to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.